Skip to Content

Methodist in the Media

Media Contacts

Mon–Fri 8am–4:30pm

 


Claudia Bohn

  • Methodist Hospital

  • Methodist Estabrook Cancer Center

  • Methodist Women's Hospital

  • Methodist Physicians Clinic

  • Methodist Physicians Clinic Women's Center

(402) 354-6818

claudia.bohn@nmhs.org

 

Vince Rew

  • Methodist Jennie Edmundson Hospital

(712) 396-6717

vince.rew@nmhs.org

 

After Hours, Weekends and Holidays

Claudia Bohn:
(402) 618-9366

Methodist In The Media

12 Dec

Doctor Thrilled by New Shingles Vaccine

Maybe you’ve heard of shingles, that ghost of chicken pox past that’s undoubtedly hiding in your nervous system, waiting for a chance to make a comeback with a blistering rash and persistent nerve pain.

Shingles and chicken pox are both caused by the same virus, varicella zoster.

Maybe you’ve heard of, or even gotten, the shingles vaccine, which is intended to head off that comeback. That shot, Zostavax, was recommended for people age 60 and over.  

Now, however, there’s a new vaccine, approved in October by an advisory committee to the CDC. That one, called Shingrix, is recommended for people age 50 and older. And this new one is more than 90 percent effective.

The best news, said Dr. Rudolf Kotula, an infectious disease physician with Methodist Physicians Clinic in Omaha, is that the new vaccine remains more than 90 percent effective even as people age. The older vaccine’s effectiveness drops off significantly over the decades.

Omaha World-Herald reporter Julie Anderson: CDC Touts New Shingles Vaccine